García-Palmieri M
Departamento de Medicina y de Cardiología de Adultos, Escuela de Medicina, Universidad de Puerto Rico.
P R Health Sci J. 1995 Sep;14(3):217-21.
Hypertension occurs in 50% of the elderly persons in industrialized societies. This disorder of the regulation of the arterial blood pressure has different manifestations in different age groups. The young hypertensive usually has an increase in cardiac output and a normal peripheral vascular resistance. The elderly patient with hypertension exhibits a decreased cardiac output and an increased peripheral vascular resistance. In the elderly hypertensive there is a progressive anteriolar narrowing and there is hardening of the largest arteries. The vascular disease that contributes to the hypertension in the elderly also causes hypoperfusion of the target organs. During the aging process there is a decrease in cardiac output, glomerular filtration rate, vital capacity, renal plasma flow and maximal cardiac rate. There are changes in the kidneys and the liver that influence the way different medications are handled by the body. The main findings of the Australian, EWPHE, Coope & Warrender, SHEP, STOP-HYP and MRC studies of hypertension in the elderly have been summarized. The intervention studies have proven that the treatment of hypertension in the elderly patient is efficacious and decreases the mortality and morbidity due to coronary and cerebrovascular events. The pharmacologic agents available for the treatment of hypertension in the elderly are the diuretics, beta blockers, vasodilators, calcium-channel blockers, adrenergic blockers and angiotensin converting enzyme inhibitors. The morbidity and mortality benefits derived from antihypertensive trials are greater for the older than for the younger patients. The pharmacologic antihypertensive agents to be used in older patients will also depend upon the presence or not of associated illnesses in which some agents might be harmful or contraindicated.(ABSTRACT TRUNCATED AT 250 WORDS)
在工业化社会中,50%的老年人患有高血压。这种动脉血压调节紊乱在不同年龄组有不同表现。年轻高血压患者通常心输出量增加,外周血管阻力正常。老年高血压患者心输出量减少,外周血管阻力增加。老年高血压患者存在小动脉逐渐狭窄,大动脉变硬。导致老年人高血压的血管疾病也会引起靶器官灌注不足。在衰老过程中,心输出量、肾小球滤过率、肺活量、肾血浆流量和最大心率都会下降。肾脏和肝脏也会发生变化,影响身体对不同药物的处理方式。本文总结了澳大利亚、EWPHE、库珀与沃伦德、SHEP、STOP - HYP和MRC关于老年人高血压研究的主要发现。干预研究证明,老年患者高血压治疗有效,可降低因冠心病和脑血管事件导致的死亡率和发病率。可用于治疗老年人高血压的药物有利尿剂、β受体阻滞剂、血管扩张剂、钙通道阻滞剂、肾上腺素能阻滞剂和血管紧张素转换酶抑制剂。降压试验对老年患者的发病率和死亡率益处大于年轻患者。老年患者使用的降压药物还将取决于是否存在某些药物可能有害或禁忌的相关疾病。(摘要截选于250词)